David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video

November 14, 2023

Earlier this year, Prime/Magellan Rx announced an analysis of GLP-1 drugs for weight loss, which found low adherence and increased cost among individuals taking the drug. In this video, David Lassen, Chief Clinical Officer, provides additional insights.

Watch the full video here.